+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Type 2 Diabetes Drug"

Global Type 2 Diabetes Drugs Market by Drug (Injectables, Oral), Application (Cardiovascular Safety, Glycemic Control, Hypoglycemia Avoidance), Distribution - Forecast 2024-2030 - Product Thumbnail Image

Global Type 2 Diabetes Drugs Market by Drug (Injectables, Oral), Application (Cardiovascular Safety, Glycemic Control, Hypoglycemia Avoidance), Distribution - Forecast 2024-2030

  • Report
  • March 2024
  • 184 Pages
  • Global
From
Global Markets for Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Global Markets for Diabetes Therapeutics and Diagnostics

  • Report
  • August 2023
  • 336 Pages
  • Global
From
Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Thumbnail Image

Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • July 2023
  • 220 Pages
  • Global
From
Type 2 Diabetes Treatment: Global Market Outlook - Product Thumbnail Image

Type 2 Diabetes Treatment: Global Market Outlook

  • Report
  • December 2022
  • 66 Pages
  • Global
From
Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025 - Product Thumbnail Image

Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025

  • Report
  • August 2020
  • 250 Pages
  • Saudi Arabia
From
Global Diabetes Drug Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis - Product Thumbnail Image

Global Diabetes Drug Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis

  • Report
  • March 2022
  • 140 Pages
  • Global
From
Japan Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

Japan Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Japan
From
Cushing's Syndrome Diagnostic And Treatment Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Cushing's Syndrome Diagnostic And Treatment Market - Forecasts from 2022 to 2027

  • Report
  • March 2022
  • 124 Pages
  • Global
From
Global Type 2 Diabetes Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Type 2 Diabetes Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Global
From
Europe Type 2 Diabetes Market and Competitive Landscape - 2021 - Product Thumbnail Image

Europe Type 2 Diabetes Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Europe
From
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 62 Pages
  • Global
From
Type 2 Diabetes - Pipeline Review, H2 2020 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1251 Pages
  • Global
From
Hyperglycemia - Pipeline Review, H1 2020 - Product Thumbnail Image

Hyperglycemia - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 35 Pages
  • Global
From
Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2018 - Product Thumbnail Image

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2018

  • Drug Pipelines
  • September 2018
  • 64 Pages
  • Global
From
Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Pipeline Review, H1 20 - Product Thumbnail Image

Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Pipeline Review, H1 20

  • Drug Pipelines
  • June 2018
  • 31 Pages
  • Global
From
Type 2 Diabetes in America 2023: Key Insights into Treatment Awareness & Satisfaction - Product Thumbnail Image

Type 2 Diabetes in America 2023: Key Insights into Treatment Awareness & Satisfaction

  • Report
  • April 2023
  • 120 Pages
  • Global
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 100 Pages
  • Global
From
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 35 Pages
  • Global
From
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1127 Pages
  • Global
From
Glucose Dependent Insulinotropic Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Glucose Dependent Insulinotropic Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 37 Pages
  • Global
From
Loading Indicator

The Type 2 Diabetes Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat Type 2 Diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin properly. Type 2 Diabetes Drugs are used to help control blood sugar levels, reduce the risk of complications, and improve overall health. These drugs can be taken orally, injected, or inhaled. Common Type 2 Diabetes Drugs include Metformin, Sulfonylureas, Thiazolidinediones, Meglitinides, DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors. Some companies in the Type 2 Diabetes Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Boehringer Ingelheim, and Takeda. Show Less Read more